Open Access131I Activity for Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Systematic Review
Author(s) -
Allan Hackshaw,
Clive Harmer,
Ujjal K. Mallick,
Masud Haq,
Jayne A. Franklyn
Publication year - 2006
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2006-1345
Subject(s) - medicine , ablation , confidence interval , thyroid cancer , meta analysis , thyroidectomy , randomized controlled trial , thyroid , nuclear medicine , urology
Radioiodine ablation of the thyroid remnant after thyroidectomy is commonly performed in the management of patients with differentiated thyroid cancer. Although many centers administer an activity of 100 mCi, there is uncertainty over using a lower activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom